Events

 

Events

Show Filters

Days

Categories

Venues

Organizers

Reset Filters
«
»
  • 15
    15
    May

    12:30 pm-2:00 pm
    05-15-2018

    RSVP

    As a biotech company matures, clinical trials will take up a disproportionate amount of resources for a clinical stage company. The CEO of Trialspark, Benjamine Liu, will give an overview of some of the opportunities to reimagine the clinical trial and significantly reduce the time and cost of development.

    Benjamin Liu, DPhil

    CEO, Trialspark

    Benjamine Liu is the co-founder and CEO of Trialspark, a technology company that runs end to-end clinical trials for biopharma. Benjamine received his DPhil from Oxford, conducting his graduate work with Sir Simon Lovestone. His doctoral thesis leveraged machine-learning and ‘omics’ to identify diagnostic tests and therapeutic targets for Parkinson’s and Alzheimer’s disease. During his graduate work, he was exposed to how clinical trials bottlenecked the development of new drugs, compelling him to start Trialspark.

  • 16
    16
    May

    12:00 pm-2:00 pm
    05-16-2018

    RSVP

    Novotech and CoSec will be onsite to discuss the advantageous Australian regulatory landscape for early phase clinical development. Fast regulatory timelines and the 43.5% research and development Tax Rebate make Australia an ideal destination for small biotech companies entering clinical trials.

    Alex Ireland, MPH

    Business Development Associate

    Alex Ireland has been working in the biotech industry for the past five years from sales to operations, and has been working for Novotech for the past year. She is passionate about working with small-biotech companies and educating them on the benefits of running clinical trials in the Asia Pacific. Born and raised in the Bay Area, she earned a Master’s Degree from Boston Pharmaceuticals in Epidemiology and International Health.

Upcoming Event

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter